Jiang Siliang, Cui Yongsheng, Wang Bo, Fu Zheng, Dong Caixia
Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China; Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, Ministry of Education, 24 Heping Road, Harbin 150040, China.
Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
Int J Biol Macromol. 2024 Dec;282(Pt 4):137207. doi: 10.1016/j.ijbiomac.2024.137207. Epub 2024 Nov 2.
Three purified polysaccharides, CDAP-1, CDAP-2, and CDAP-3, were prepared from the rhizome of Cistanche deserticola and characterized. Structural analysis revealed that CDAP-1 and CDAP-2 are highly branched RG-I-type polysaccharides with side chains, including arabinans, galactans, and/or AGs, whereas CDAP-3 is a typical HG-type polysaccharide. In vivo tests revealed that treatment with the crude polysaccharide fraction (CDCP) significantly prolonged the survival of H22 tumor-bearing mice and exhibited antitumor effects. In vitro experiments demonstrated that all three polysaccharides could polarize M2-like TAMs toward the M1 phenotype. As a major component of CDCP, CDAP-2 could act on M2 macrophages through the TLR4 receptor-mediated NF-κB signaling pathway. An in vitro cell model verified that CDAP-2 could inhibit cell proliferation by reversing the polarization of M2-like TAMs to the cytotoxic M1 phenotype. Overall, we found that CDCP showed a clear antitumor effect and that its major component, CDAP-2, could reverse the suppressive TAM phenotype in the microenvironment, providing a scientific basis for the clinical application and development of C. deserticola.
从肉苁蓉根茎中制备了三种纯化的多糖CDAP-1、CDAP-2和CDAP-3,并对其进行了表征。结构分析表明,CDAP-1和CDAP-2是高度分支的带有侧链的RG-I型多糖,侧链包括阿拉伯聚糖、半乳聚糖和/或阿拉伯半乳聚糖,而CDAP-3是典型的HG型多糖。体内试验表明,粗多糖组分(CDCP)处理可显著延长荷H22肿瘤小鼠的生存期,并表现出抗肿瘤作用。体外实验表明,这三种多糖均可使M2样肿瘤相关巨噬细胞(TAM)向M1表型极化。作为CDCP的主要成分,CDAP-2可通过TLR4受体介导的NF-κB信号通路作用于M2巨噬细胞。体外细胞模型证实,CDAP-2可通过将M2样TAM的极化逆转至具有细胞毒性的M1表型来抑制细胞增殖。总体而言,我们发现CDCP具有明显的抗肿瘤作用,其主要成分CDAP-2可逆转微环境中TAM的抑制表型,为肉苁蓉的临床应用和开发提供了科学依据。